ANI Pharmaceuticals
ANIP
#5360
Rank
NZ$2.85 B
Marketcap
NZ$124.43
Share price
-1.57%
Change (1 day)
-19.42%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): NZ$7.08

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$6.89. In 2025 the company made an earnings per share (EPS) of NZ$5.87 an increase over its 2024 EPS that were of NZ-$1.88.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.0820.54%
2025NZ$5.87-412.5%
2024NZ-$1.88
2022NZ-$5.10-6.46%
2021NZ-$5.4572.87%
2020NZ-$3.15-476%
2019NZ$0.84-62.12%
2018NZ$2.21
2015NZ$2.25-47.66%
2014NZ$4.29-142.11%
2013NZ-$10.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.78 70.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.20-68.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$11.02 59.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$0.77-88.81%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ-$4.23-161.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.15-203.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.30-66.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$3.20-53.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ-$42.41-715.09%๐Ÿ‡บ๐Ÿ‡ธ USA